Hello and Welcome to Patientsville.com, Your Source for all MIDAZOLAM information. We are dedicated to provide You with MIDAZOLAM safety information. Learn about MIDAZOLAM serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MIDAZOLAM Safety Reports
Total MIDAZOLAM reports: 78.MIDAZOLAM FDA safety alerts: 2002 .
Reported deaths: 4 Reported hospitalizations: 29.
Take MIDAZOLAM Side Effects Survey or Share Your MIDAZOLAM Story. Read More Here.
Showing 1-75 of 78 Next >
Consumer or non-health professional from UNITED KINGDOM reported MIDAZOLAM problem on Sept 04, 2007. Male patient, 87 years of age, was diagnosed with sedation and was treated with MIDAZOLAM. After drug was administered, patient experienced the following problems/side effects: condition aggravated, laryngospasm, respiratory disorder, stridor. MIDAZOLAM dosage: 3 MG TOTAL IV. Patient was hospitalized. Patient died on 07/24/2007.MIDAZOLAM problem was reported by a Consumer or non-health professional from on Sept 19, 2007. Female patient, 70 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with MIDAZOLAM. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, blood pressure systolic decreased, cardiovascular insufficiency, delayed recovery from anaesthesia, tachycardia. MIDAZOLAM dosage: unknown. During the same period patient was treated with ETOMIDATE, SUFENTANIL CITRATE, ROCURONIUM BROMIDE, PROPOFOL, CYCLOSPORINE, METHYLPREDNISOLONE, METOPROLOL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported MIDAZOLAM problem on Sept 07, 2007. Female patient, weighting 31.53 lb, was diagnosed with amnesia, analgesia and was treated with MIDAZOLAM. After drug was administered, patient experienced the following problems/side effects: anaesthetic complication, atrioventricular block first degree, bradycardia, electrocardiogram qrs complex prolonged, procedural complication, pulse absent. MIDAZOLAM dosage: 0.5 UNK, MG/H. During the same period patient was treated with MIDAZOLAM HYDROCHLORIDE, THIOPENTAL, SUXAMETHONIUM CHLORIDE, VECURONIUM BROMIDE, MORPHINE, SUCCINYLCHLOLINE CHLORIDE. Patient recovered.
Showing 1-75 of 78 Next >